| (ii) |
omit from a list of quotations of prices of financial instruments issued for publication on the authority of the executive committee, the prices of any financial instruments previously quoted in this list; or |
| (b) |
an executive officer of a financial exchange may, whenever he is of the opinion that it is desirable, also for the purposes of compliance with and enforcement of the rules and other requirements of the financial exchange in respect of the listing of financial instruments, in accordance with the rules in question, without prior notice to any person and without hearing any person, suspend for a period not exceeding 30 days the inclusion of financial instruments in the list referred to in section 14. |
[Paragraph (b) substituted by section 24 of Act 54 of 1991]
| (2) |
No removal, suspension or omission referred to in subsection (1) (a) shall be effected by the executive committee on a ground in respect of which the person who issued the financial instruments has not had the opportunity of making representations to the executive committee in support of the continued inclusion of the financial instruments or prices in the relevant list. |
| (a) |
a removal or suspension of listed financial instruments by an executive committee in terms of subsection (1) (a); or |
| (b) |
a suspension of listed financial instruments by an executive officer in terms of subsection (1) (b), |
the executive committee or executive officer, as the case may be, may, notwithstanding section 14, permit members to deal on the financial market in the financial instruments in question for the sole purpose of fulfilling their obligations entered into before the removal or suspension.
| (4) |
[Subsection (4) deleted by section 11 of Act 55 of 1995] |
Medicines and Related Substances Act, 1965
